Annual Operating Profit
-$415.57 M
-$239.08 M-135.47%
December 31, 2024
Summary
- As of March 13, 2025, BEAM annual operating income is -$415.57 million, with the most recent change of -$239.08 million (-135.47%) on December 31, 2024.
- During the last 3 years, BEAM annual operating profit has fallen by -$23.10 million (-5.89%).
- BEAM annual operating profit is now -808.52% below its all-time high of -$45.74 million, reached on December 31, 2018.
Performance
BEAM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$100.04 M
+$6.47 M+6.07%
December 31, 2024
Summary
- As of March 13, 2025, BEAM quarterly operating income is -$100.04 million, with the most recent change of +$6.47 million (+6.07%) on December 31, 2024.
- Over the past year, BEAM quarterly operating profit has increased by +$4.86 million (+4.63%).
- BEAM quarterly operating profit is now -175.30% below its all-time high of $132.86 million, reached on December 31, 2023.
Performance
BEAM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$415.57 M
-$232.90 M-127.49%
December 31, 2024
Summary
- As of March 13, 2025, BEAM TTM operating income is -$415.57 million, with the most recent change of -$232.90 million (-127.49%) on December 31, 2024.
- Over the past year, BEAM TTM operating profit has dropped by -$231.13 million (-125.32%).
- BEAM TTM operating profit is now -3175.28% below its all-time high of -$12.69 million, reached on September 30, 2018.
Performance
BEAM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BEAM Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -135.5% | +4.6% | -125.3% |
3 y3 years | -5.9% | -57.6% | -5.9% |
5 y5 years | -453.0% | -279.3% | -453.0% |
BEAM Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -135.5% | at low | -175.3% | +7.6% | -135.5% | at low |
5 y | 5-year | -453.0% | at low | -175.3% | +50.1% | -453.0% | at low |
alltime | all time | -808.5% | at low | -175.3% | +50.1% | -3175.3% | at low |
Beam Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$415.57 M(+135.5%) | -$100.04 M(-6.1%) | -$415.57 M(+127.5%) |
Sep 2024 | - | -$106.50 M(+1.5%) | -$182.67 M(-1.0%) |
Jun 2024 | - | -$104.89 M(+0.7%) | -$184.44 M(+1.5%) |
Mar 2024 | - | -$104.13 M(-178.4%) | -$181.69 M(+2.9%) |
Dec 2023 | -$176.49 M(-47.9%) | $132.86 M(-222.7%) | -$176.49 M(-55.7%) |
Sep 2023 | - | -$108.27 M(+6.0%) | -$398.33 M(+4.4%) |
Jun 2023 | - | -$102.15 M(+3.3%) | -$381.36 M(+5.6%) |
Mar 2023 | - | -$98.93 M(+11.2%) | -$361.18 M(+6.7%) |
Dec 2022 | -$338.48 M(-13.8%) | -$88.98 M(-2.5%) | -$338.48 M(+8.1%) |
Sep 2022 | - | -$91.30 M(+11.4%) | -$312.98 M(+7.4%) |
Jun 2022 | - | -$81.97 M(+7.5%) | -$291.31 M(+8.6%) |
Mar 2022 | - | -$76.22 M(+20.1%) | -$268.32 M(-31.6%) |
Dec 2021 | -$392.46 M | -$63.48 M(-8.8%) | -$392.46 M(+6.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$69.63 M(+18.1%) | -$369.78 M(+9.6%) |
Jun 2021 | - | -$58.97 M(-70.6%) | -$337.47 M(+10.7%) |
Mar 2021 | - | -$200.37 M(+391.1%) | -$304.78 M(+129.6%) |
Dec 2020 | -$132.76 M(+76.7%) | -$40.80 M(+9.3%) | -$132.76 M(+12.2%) |
Sep 2020 | - | -$37.32 M(+42.0%) | -$118.33 M(+19.5%) |
Jun 2020 | - | -$26.29 M(-7.3%) | -$99.03 M(+9.6%) |
Mar 2020 | - | -$28.36 M(+7.5%) | -$90.40 M(+20.3%) |
Dec 2019 | -$75.15 M(+64.3%) | -$26.37 M(+46.3%) | -$75.15 M(+20.5%) |
Sep 2019 | - | -$18.02 M(+2.1%) | -$62.35 M(+9.4%) |
Jun 2019 | - | -$17.65 M(+34.7%) | -$57.01 M(+44.8%) |
Mar 2019 | - | -$13.11 M(-3.4%) | -$39.36 M(+49.9%) |
Dec 2018 | -$45.74 M | -$13.56 M(+6.9%) | -$26.25 M(+106.9%) |
Sep 2018 | - | -$12.69 M | -$12.69 M |
FAQ
- What is Beam Therapeutics annual operating income?
- What is the all time high annual operating profit for Beam Therapeutics?
- What is Beam Therapeutics annual operating profit year-on-year change?
- What is Beam Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Beam Therapeutics?
- What is Beam Therapeutics quarterly operating profit year-on-year change?
- What is Beam Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Beam Therapeutics?
- What is Beam Therapeutics TTM operating profit year-on-year change?
What is Beam Therapeutics annual operating income?
The current annual operating profit of BEAM is -$415.57 M
What is the all time high annual operating profit for Beam Therapeutics?
Beam Therapeutics all-time high annual operating income is -$45.74 M
What is Beam Therapeutics annual operating profit year-on-year change?
Over the past year, BEAM annual operating income has changed by -$239.08 M (-135.47%)
What is Beam Therapeutics quarterly operating income?
The current quarterly operating profit of BEAM is -$100.04 M
What is the all time high quarterly operating profit for Beam Therapeutics?
Beam Therapeutics all-time high quarterly operating income is $132.86 M
What is Beam Therapeutics quarterly operating profit year-on-year change?
Over the past year, BEAM quarterly operating income has changed by +$4.86 M (+4.63%)
What is Beam Therapeutics TTM operating income?
The current TTM operating profit of BEAM is -$415.57 M
What is the all time high TTM operating profit for Beam Therapeutics?
Beam Therapeutics all-time high TTM operating income is -$12.69 M
What is Beam Therapeutics TTM operating profit year-on-year change?
Over the past year, BEAM TTM operating income has changed by -$231.13 M (-125.32%)